BUZZ - Personalis stock drops as BTIG lowers rating and expects no bidding for Tempus deal
路透社2026/10/06 14:31October 6 – Personalis (PSNL.O) shares fell about 2% to $16.12. BTIG downgraded the cancer screening company from “Buy” to “Neutral.” The brokerage stated that Tempus AI TEM.O will complete its acquisition of PSNL in the coming months; and believes that “despite an ongoing bidding process,” no higher offer will emerge. Tempus AI has agreed to acquire Personalis by July 2026 (link), with a deal valued at approximately $1.5 billions. Out of five brokerages, one has assigned a “Strong Buy” rating to the stock, while four have rated it “Hold,” with a median price target of $16.25—data compiled by LSEG. Including today’s gains, the stock has risen a cumulative 104.40% so far this year. (To facilitate non-English speakers, Reuters has automated this report into several other languages. Because automated translation may contain errors or lack the desired context, Reuters does not guarantee the accuracy of such translations and provides them solely for the reader’s convenience. Reuters assumes no liability for any damage or loss arising from the use of automated translation.)
October 6 - ** Personalis (PSNL.O) shares fell about 2% to $16.12
** BTIG downgraded the cancer testing company from "Buy" to "Neutral"
** The brokerage said Tempus AI TEM.O will complete the acquisition of PSNL in the coming months; it believes that "despite the bidding process," there will be no higher offer
** Tempus AI has agreed to acquire Personalis (link) in July 2026, with the deal valued at about $1.5 billion
** Of five analysts, one rates the stock as "Strong Buy" and four rate it as "Hold," with a median price target of $16.25—data compiled by LSEG
** Including today's gain, the stock has risen a cumulative 104.40% so far this year
(To facilitate non-native English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of translated texts and provides them for readers’ convenience only. Reuters accepts no responsibility for any losses or damages arising from the use of automated translation functions.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jefferies raises Tesla's target price to $400
Goldman Sachs (GS.US) stock plunges 22% into bear market, financial report becomes the key to a breakthrough
Goldman Sachs' market value evaporated by several billions, with its share price down more than 22% from the year's high. Despite Q3 revenue exceeding expectations, a 41% drop in M&A activity and a slowdown in IPOs have dampened market sentiment. Analysts project a 12% revenue increase in Q4, but technical indicators suggest there is further downside risk to $783. Rumors about management transitions have also drawn attention.
Crypto prices
More
